This study will elucidate the pharmacogenetic effects of the Asn40Asp SNP of the OPRM1 gene
on biobehavioral and neural markers of response to naltrexone in individuals of East Asian
descent, an ethnic group most likely to express the positive predictive allele.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, Los Angeles
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)